Abstract
AbstractIndolcarboxamides are a promising series of anti-tubercular agents which targetMycobacterium tuberculosisMmpL3, the exporter of trehalose monomycolate, a key cell wall component. We determined the kill kinetics of the lead indolcarboxamide NITD-349 and determined that while kill was rapid against low density cultures, bactericidal activity was inoculum-dependent. A combination of NITD-349 with isoniazid (which inhibits mycolate synthesis) had an increased kill rate; this combination prevented the appearance of resistant mutants, even at higher inocula.
Publisher
Cold Spring Harbor Laboratory